查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011620

医疗保健领域3D列印石膏市场：按材料、技术、印表机类型、应用和最终用户划分－2026-2032年全球市场预测

3D Printing Casts in Healthcare Market by Material, Technology, Printer Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗领域的 3D 列印铸件市值将达到 3.2855 亿美元，到 2026 年将成长至 3.8225 亿美元，到 2032 年将达到 9.9391 亿美元，年复合成长率为 17.13%。

主要市场统计数据
基准年 2025 3.2855亿美元
预计年份：2026年 3.8225亿美元
预测年份：2032年 9.9391亿美元
复合年增长率 (%) 17.13%

医用石膏的3D列印技术已迅速从实验性的研究发展成为一种临床工具，使临床医生能够重新思考固定方法、患者舒适度和个人化护理路径。扫描仪精度、积层製造流程和生物相容性材料的进步，使得生产轻盈透气、符合患者需求的石膏成为可能，从而满足了临床和使用者体验的双重目标。因此，由临床医生、生物医学工程师和製造专家组成的多学科团队，越来越多地将3D列印石膏视为更广泛的数位化护理工作流程的一部分，而非独立产品。

从传统的石膏或预製模型过渡到数位化製造模型，需要对采购、临床通讯协定和人员能力进行调整。临床列印模式与专业实验室的集中生产并存，形成了一种混合服务架构，从而优化了交付时间和成本。同时，材料化学性能和灭菌技术的不断改进降低了临床应用门槛，并扩大了列印模型具有明显优势的适应症范围。简而言之，这项技术在带来切实临床益处的同时，也要求医疗服务模式进行重组，因此，对于考虑实施该技术的医疗机构而言，策略规划至关重要。

透过重新思考铸件製造、消毒、材料科学和临床环境中的客製化，来变革技术和临床实践。

医用石膏领域正经历着一场变革性的转型，这主要得益于技术和临床因素的共同作用。首先，数位影像和电脑辅助设计（CAD）工作流程的成熟，使得临床医生能够精确捕捉人体解剖结构，并将其转化为兼顾固定性、舒适性和皮肤健康的实用设计。因此，临床医生可以从「一刀切」的治疗模式转向真正个人化的治疗，从而有望提高患者的治疗依从性并缩短恢復时间。

分析 2025 年美国关税措施对材料、设备和临床部署的累积营运和供应链影响。

2025年实施的政策变化和关税措施对支持医用模型3D列印的全球供应链产生了复杂且累积的影响。这些措施影响了特殊粉末、树脂和印表机组件等关键原料的供应和成本，促使製造商重新评估其筹资策略。为此，一些供应商采取了近岸外包和双重采购安排，以降低单一供应商带来的风险；而另一些供应商则加快了垂直整合，以确保向临床客户持续供应原材料。

将铸件的材料特性、印刷技术、印表机类型、临床应用和最终用户趋势连结起来进行細項分析。

要了解市场，需要对材料、技术、列印平台、临床应用案例和终端用户环境进行深入观点，因为每个方面在性能和法规方面都存在不同的权衡取舍。材料种类繁多，从氧化铝和氧化锆等先进陶瓷到碳纤维和玻璃纤维复合材料体系，再到不銹钢和钛等金属，可满足特定的结构需求。聚合物包括针对高解析度细节最佳化的光敏聚合物，以及注重耐久性的热塑性树脂。每个材料类别不仅决定了3D列印模型适用的临床适应症，还决定了满足安全和消毒标准所需的列印技术和后处理流程。

对全球主要地区的需求驱动因素、监管影响、製造地和临床引入准备进行全面的区域展望。

受医疗服务模式、报销机制和製造生态系统差异的影响，区域趋势对列印铸造技术的应用、监管和商业化产生了重大影响。在美洲，创新往往围绕着临床卓越中心和能够投资于第一线功能的私人专科医疗机构展开，而区域供应链和监管流程则支援快速试验计画和商业化测试。这种环境促进了技术供应商与医疗服务提供者网路之间的伙伴关係，以优化工作流程并展现临床价值。

这是企业级竞争分析，重点在于影响临床模型采用的产品系列、垂直整合伙伴关係、智慧财产权策略和服务模式。

企业级列印铸件领域的趋势反映了产品创新、垂直整合、策略伙伴关係以及服务主导差异化的综合作用。结合专有材料、检验的工艺流程和强有力的临床证据的市场参与企业，正在创造可持续的价值提案，从而引起风险规避型医疗保健负责人的共鸣。同时，专注于建构开放平台和生态系统的公司，往往能够透过降低临床团队和第三方服务供应商的技术门槛，加速产品的普及应用。

为製造商、医疗保健提供者和材料创新者提供实用的策略建议，以加速采用安全、可扩展和高效的铸造解决方案。

产业领导企业应推动一系列合作倡议，将技术潜力转化为永续的临床和商业性成果。首先，投资检验的端到端工作流程，整合成像、设计、列印和灭菌等环节，确保这些工作流程具备临床证据和标准化操作规程，以便临床医生能够放心采用。其次，建立完善的临床团队训练计画和认证流程，最大限度地减少差异，加速医疗保健领域的应用。

本节概述了一种严谨的混合方法检验调查方法，该方法包括专家参与、证据整合和三角验证方法来检验研究结果。

本报告的研究结果基于混合方法研究，该方法强调与第一线专家的深入交流、系统性证据的整合以及迭代三角验证，以检验研究结果。一手研究包括对临床医生、生物医学工程师、采购经理和监管专家进行结构化访谈，以了解实际应用中的限制和创新路径。二手研究整合了同行评审文献、技术标准和公开的监管指南，以阐明在既定的安全和品质框架内进行技术评估的合理性。

摘要重点阐述了临床影响、营运重点以及将 3D 列印铸造技术与相关人员。

现有证据表明，3D列印石膏模型既带来了临床机会，也带来了营运挑战，需要技术、监管和临床实践等多个环节来协同应对。若运用得当，3D列印石膏模型可提升病患体验，实现个人化治疗，并透过数位化流程简化工作流程。然而，要大规模实现这些优势，需要检验的材料、可重复的製造流程、稳健的供应链以及将新技术融入日常实践的培训项目。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗保健领域3D列印铸件市场：依材料分类

  • 陶瓷製品
    • 氧化铝
    • 氧化锆
  • 复合材料
    • 碳纤维
    • 玻璃纤维
  • 金属
    • 防锈的
    • 钛
  • 聚合物
    • 光聚合树脂
    • 热塑性树脂

第九章：医疗保健领域3D列印铸件市场：依技术划分

  • 黏着剂喷涂成型
  • DLP
  • FDM
    • 封闭式源
    • 开放原始码
  • PolyJet
  • SLA
    • 数位光处理
    • 雷射SLA
  • SLS

第十章：医疗保健领域3D列印铸件市场：依印表机类型划分

  • 桌上型印表机
  • 工业印表机

第十一章：医疗保健领域3D列印铸件市场：依应用领域划分

  • 牙科
    • 矫正器
    • 桥
    • 王冠
    • 植入
  • 整形外科
    • 投掷
    • 骨折固定
    • 植入
  • 义肢
    • 脸部假体
    • 下肢
    • 上肢
  • 手术导板
    • 颅骨
    • 牙科
    • 整形外科
    • 脊椎

第十二章：医疗保健领域3D列印铸件市场：依最终用户划分

  • 牙体技术所
  • 医院和诊所
  • 研究机构

第十三章：医疗保健领域3D列印铸件市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：医疗保健领域3D列印铸件市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：医疗保健领域3D列印铸件市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗保健领域的3D列印石膏市场

第十七章：中国医疗保健领域的3D列印石膏市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3D Systems Corporation
  • Arcam AB
  • Carbon, Inc.
  • Desktop Metal, Inc.
  • EnvisionTEC GmbH
  • EOS GmbH
  • Formlabs Inc.
  • General Electric Company
  • HP Inc.
  • Markforged, Inc.
  • Materialise NV
  • Organovo Holdings, Inc.
  • Prodways Group
  • Protolabs, Inc.
  • Renishaw plc
  • SLM Solutions Group AG
  • Stratasys Ltd.
  • Voxeljet AG
Product Code: MRR-43676CF42386

The 3D Printing Casts in Healthcare Market was valued at USD 328.55 million in 2025 and is projected to grow to USD 382.25 million in 2026, with a CAGR of 17.13%, reaching USD 993.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 328.55 million
Estimated Year [2026] USD 382.25 million
Forecast Year [2032] USD 993.91 million
CAGR (%) 17.13%

Three-dimensional printing of medical casts has moved rapidly from an experimental curiosity to a clinical tool that reshapes how clinicians conceive of immobilization, patient comfort, and personalized care pathways. Advances in scanner accuracy, additive manufacturing processes, and biocompatible materials now enable the production of lightweight, ventilated, and patient-specific casts that address both clinical and experiential objectives. As a result, multidisciplinary teams composed of clinicians, biomedical engineers, and manufacturing specialists increasingly view printed casts as part of a broader digital care workflow rather than as a standalone product.

Transitioning from traditional plaster and prefabricated splints to digitally manufactured casts requires changes across procurement, clinical protocols, and staff capabilities. Point-of-care printing models coexist with centralized production at specialty labs, creating hybrid service architectures that optimize turnaround and cost. Meanwhile, iterative improvements in material chemistries and sterilization practices reduce barriers to clinical adoption and expand the range of indications where printed casts offer clear advantages. In short, the technology offers tangible clinical benefits while simultaneously demanding a reorientation of care delivery models, which makes strategic planning essential for institutions evaluating adoption.

Transformative technology and clinical practice shifts reshaping manufacturing, sterilization, materials science, and point-of-care customization for casts

The landscape of medical casting is undergoing transformative shifts driven by several converging technological and clinical forces. First, the maturation of digital imaging and CAD workflows enables clinicians to capture precise anatomical geometries and translate them into functional designs that balance immobilization with comfort and skin health. As a consequence, clinicians can move from one-size-fits-most approaches to truly bespoke treatments, which improves adherence and can shorten recovery timelines.

Second, material science innovations have broadened the palette of feasible solutions, spanning rigid supports, semi-rigid lattices, and soft interfaces that reduce pressure points. These material advances paired with process improvements in resolution and repeatability allow for casts that meet stringent biocompatibility and mechanical performance criteria, thereby expanding clinical acceptance. Third, operational practices are shifting as hospitals and specialty labs adopt on-site manufacturing and just-in-time production models, which reduce lead times and improve responsiveness to acute cases.

Finally, regulatory and quality frameworks are adapting to accommodate point-of-care manufacturing, with increased emphasis on process validation, traceability, and clinician training. Collectively, these shifts transform not only the product but the ecosystem surrounding it, necessitating new partnership models among device makers, materials suppliers, software companies, and clinical providers.

Analyzing the cumulative operational and supply chain effects of United States tariff actions in 2025 on materials, equipment, and clinical adoption

Policy changes and tariff actions implemented in 2025 have exerted a complex, cumulative influence on the global supply chains that support 3D printing of medical casts. These measures affected the availability and cost of critical inputs such as specialized powders, resins, and printer components, prompting manufacturers to re-evaluate sourcing strategies. In response, some suppliers pursued nearshoring and dual-sourcing arrangements to mitigate single-origin risk, while others accelerated vertical integration to secure continuity of supply for clinical customers.

Clinics and laboratories experienced secondary impacts as lead times for certain feedstocks extended and acquisition costs for advanced printers and sterilization equipment rose. Consequently, many organizations reassessed their capital investment plans and operational models, shifting toward shared-service arrangements and regional manufacturing hubs that dilute tariff exposure. At the same time, vendors and service providers emphasized modular product lines and subscription models that ease the upfront burden for healthcare providers.

Regulatory stakeholders and procurement leaders reacted by prioritizing transparent supply chains, supplier qualification protocols, and inventory resilience. These adaptations reduced immediate disruption and created opportunities for suppliers that could demonstrate reliable local warehousing, validated sourcing, and responsive technical support. Looking forward, the net effect of the 2025 tariff environment is an acceleration of supply-chain modernization and an emphasis on provider-centric service models that enhance clinical reliability despite geopolitical headwinds.

Segmentation intelligence connecting material properties, printing technologies, printer classes, clinical applications, and end-user dynamics for casts

Understanding the market requires a granular view across materials, technologies, print platforms, clinical use cases, and end-user settings, because each axis imposes distinct performance and regulatory trade-offs. Materials range from advanced ceramics like alumina and zirconia to composite systems that incorporate carbon fiber or glass fiber, and to metals such as stainless steel and titanium for specific structural needs, while polymers span photopolymers optimized for high-resolution detail and thermoplastics engineered for durability. Each material class dictates not only the clinical indications where a printed cast is appropriate but also the print technology and post-processing workflows required to meet safety and sterilization standards.

Print technology choices further differentiate solutions: binder jetting and powder-bed processes deliver unique advantages for metals and certain polymers, DLP and photopolymer approaches enable fine surface detail useful in facial prosthetics and dental crowns, and FDM offers cost-effective production with variants in closed-source and open-source implementations that influence validation pathways. Meanwhile, SLA encompasses both digital light processing and laser-based subtypes, delivering a spectrum of resolution and throughput characteristics. Printer class is also consequential, since desktop printers support decentralized, point-of-care workflows with rapid iteration, whereas industrial printers provide scale and consistency for centralized manufacturing.

Clinical applications reflect this technical diversity. Dental use cases include aligners, bridges, crowns, and implants that require tight tolerances and material biocompatibility, while orthopedic needs span casts, fracture fixation devices, and implants that demand mechanical robustness. Prosthetics cover facial prosthetics and limb solutions for lower and upper limbs where esthetics and function intersect, and surgical guides used in cranial, dental, orthopedic, and spinal procedures require both precision and sterilization compatibility. Finally, end-user environments such as dental labs, hospital clinics, and research institutes shape procurement cycles, validation expectations, and adoption velocity, because each setting maintains distinct clinical governance and operational capabilities. By synthesizing these segmentation lenses, decision-makers can align material selection, technology procurement, and operational design with their intended clinical and commercial objectives.

Comprehensive regional perspectives on demand drivers, regulatory influences, manufacturing footprints, and clinical readiness across global macro regions

Regional dynamics materially influence how technologies for printed casts are adopted, regulated, and commercialized, driven by differences in healthcare delivery models, reimbursement frameworks, and manufacturing ecosystems. In the Americas, innovation tends to coalesce around clinical centers of excellence and private specialty providers that can invest in point-of-care capabilities, while regional supply chains and regulatory processes support rapid pilot programs and commercialization trials. This environment encourages partnerships between technology vendors and provider networks to refine workflows and demonstrate clinical value.

In Europe, Middle East & Africa, regulatory harmonization efforts and established medical device pathways create a landscape where conformity assessment and clinical evidence are central to adoption. Meanwhile, regional clusters with strong materials science and medical device manufacturing capabilities support nearshore production models that reduce lead times and enhance quality control. Policy incentives and public health procurement strategies further shape adoption patterns, particularly in nationalized healthcare settings.

Across the Asia-Pacific region, a combination of fast-growing clinical demand, strong manufacturing capacity, and supportive industrial policy accelerates scaling of printed cast solutions. High-volume producers and a rapidly expanding base of clinical adopters create fertile ground for cost-driven innovations and export-oriented manufacturing. Taken together, these regional contrasts require suppliers and providers to tailor commercialization strategies, regulatory approaches, and service delivery models to local conditions while maintaining interoperability and quality across geographies.

Competitive company-level intelligence highlighting product portfolios, vertical partnerships, IP strategies, and service models shaping clinical cast adoption

Company-level dynamics in the printed cast space reflect a mix of product innovation, vertical integration, strategic partnerships, and service-led differentiation. Market participants that combine proprietary materials with validated process workflows and strong clinical evidence create durable value propositions that resonate with risk-averse healthcare buyers. Conversely, firms that focus on open platforms and ecosystem enablement tend to accelerate adoption by lowering technical barriers for clinical teams and third-party service providers.

Strategic alliances between device manufacturers, materials suppliers, and software vendors shape product roadmaps and accelerate pathway-to-clinic. Intellectual property strategies around materials chemistries, lattice design software, and post-processing workflows remain central to competitive positioning, while companies that invest in robust regulatory and quality systems reduce adoption friction among hospitals and clinics. Additionally, vertically integrated service models that offer scanning, design, printing, and post-processing as a turnkey solution appeal to end users that lack in-house manufacturing expertise.

Service differentiation also manifests through training, clinical validation studies, and bundled maintenance or subscription offerings that lower technical risk for purchasers. Firms that balance innovation with clinical evidence generation and supply-chain transparency tend to secure preferred-supplier status with larger healthcare systems, while niche players focus on high-value clinical segments such as craniofacial prosthetics or orthopedic implants where specialized capabilities command premium positioning.

Actionable strategic recommendations for manufacturers, healthcare providers, and materials innovators to accelerate safe, scalable, and efficient cast solutions

Industry leaders should pursue a coordinated set of actions to translate technological potential into sustainable clinical and commercial outcomes. First, invest in validated end-to-end workflows that integrate imaging, design, printing, and sterilization, and ensure these workflows are accompanied by clinical evidence and standardized operating procedures that clinicians can adopt reliably. Establishing robust training programs and credentialing paths for clinical teams minimizes variability and accelerates institutional buy-in.

Second, diversify supply chains through regional partnerships and dual-sourcing strategies while prioritizing suppliers that demonstrate consistent quality and regulatory compliance. This approach reduces vulnerability to geopolitical and tariff-related disruptions and supports predictable clinical operations. Third, pursue partnership models that align incentives across OEMs, materials providers, and clinical service organizations so that reimbursement pathways and service-level agreements reflect shared outcomes.

Fourth, engage proactively with regulators and standards bodies to shape pragmatic validation frameworks that balance innovation with patient safety. Finally, adopt commercial models that lower barriers to entry for healthcare providers, including phased pilots, shared-service centers, and subscription-based equipment access, which enable broader clinical experimentation and eventual scale-up. Collectively, these steps create the operational resilience and clinical trust necessary for widescale adoption.

Rigorous mixed-method research methodology outlining expert engagements, evidence synthesis, and triangulation approaches for validating insights

The insights in this report derive from a mixed-method research approach that emphasizes primary expert engagement, systematic evidence synthesis, and iterative triangulation to validate findings. Primary research included structured interviews with clinicians, biomedical engineers, procurement leaders, and regulatory specialists to capture real-world constraints and innovation pathways. Secondary research synthesized peer-reviewed literature, technical standards, and publicly available regulatory guidance to ground technological assessments within established safety and quality frameworks.

Data triangulation combined qualitative insights with technology-readiness evaluations and supply-chain mapping to ensure conclusions reflected both current practice and near-term trajectories. The research process also applied scenario analysis to assess sensitivity to variables such as regulatory shifts, input availability, and price pressures. To maintain rigor, findings underwent multi-stakeholder validation workshops where divergent perspectives were reconciled and key assumptions stress-tested. Finally, ethical research practices, including consent for interviews and anonymization of proprietary inputs, ensured the integrity and defensibility of the conclusions presented.

Closing synthesis emphasizing clinical impact, operational priorities, and next steps for stakeholders to integrate 3D printed cast innovations

The cumulative evidence indicates that 3D printed casts represent both a clinical opportunity and an operational challenge that requires coordinated responses across technology, regulation, and clinical practice. When implemented thoughtfully, printed casts improve patient experience, enable personalized treatment pathways, and unlock efficiencies through digital workflows. However, realizing these benefits at scale depends on validated materials, reproducible manufacturing processes, resilient supply chains, and training programs that embed new capabilities into routine care.

Stakeholders must therefore prioritize pragmatic pilots that produce clinical evidence, invest in interoperable workflows that bridge imaging and manufacturing, and pursue collaborative procurement strategies that reduce capital barriers. By doing so, clinicians and industry partners can accelerate the transition from isolated innovations to standardized, safe, and cost-effective care options. In closing, the technology's promise is real, but its impact will depend on disciplined commercialization, evidence generation, and cross-sector collaboration to ensure patient safety and operational sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 3D Printing Casts in Healthcare Market, by Material

  • 8.1. Ceramics
    • 8.1.1. Alumina
    • 8.1.2. Zirconia
  • 8.2. Composites
    • 8.2.1. Carbon Fiber
    • 8.2.2. Glass Fiber
  • 8.3. Metals
    • 8.3.1. Stainless Steel
    • 8.3.2. Titanium
  • 8.4. Polymers
    • 8.4.1. Photopolymers
    • 8.4.2. Thermoplastics

9. 3D Printing Casts in Healthcare Market, by Technology

  • 9.1. Binder Jetting
  • 9.2. DLP
  • 9.3. FDM
    • 9.3.1. Closed Source
    • 9.3.2. Open Source
  • 9.4. PolyJet
  • 9.5. SLA
    • 9.5.1. Digital Light Processing
    • 9.5.2. Laser SLA
  • 9.6. SLS

10. 3D Printing Casts in Healthcare Market, by Printer Type

  • 10.1. Desktop Printers
  • 10.2. Industrial Printers

11. 3D Printing Casts in Healthcare Market, by Application

  • 11.1. Dental
    • 11.1.1. Aligners
    • 11.1.2. Bridges
    • 11.1.3. Crowns
    • 11.1.4. Implants
  • 11.2. Orthopedics
    • 11.2.1. Casts
    • 11.2.2. Fracture Fixation
    • 11.2.3. Implants
  • 11.3. Prosthetics
    • 11.3.1. Facial Prosthetics
    • 11.3.2. Lower Limb
    • 11.3.3. Upper Limb
  • 11.4. Surgical Guides
    • 11.4.1. Cranial
    • 11.4.2. Dental
    • 11.4.3. Orthopedic
    • 11.4.4. Spinal

12. 3D Printing Casts in Healthcare Market, by End User

  • 12.1. Dental Labs
  • 12.2. Hospitals Clinics
  • 12.3. Research Institutes

13. 3D Printing Casts in Healthcare Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. 3D Printing Casts in Healthcare Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. 3D Printing Casts in Healthcare Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States 3D Printing Casts in Healthcare Market

17. China 3D Printing Casts in Healthcare Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3D Systems Corporation
  • 18.6. Arcam AB
  • 18.7. Carbon, Inc.
  • 18.8. Desktop Metal, Inc.
  • 18.9. EnvisionTEC GmbH
  • 18.10. EOS GmbH
  • 18.11. Formlabs Inc.
  • 18.12. General Electric Company
  • 18.13. HP Inc.
  • 18.14. Markforged, Inc.
  • 18.15. Materialise NV
  • 18.16. Organovo Holdings, Inc.
  • 18.17. Prodways Group
  • 18.18. Protolabs, Inc.
  • 18.19. Renishaw plc
  • 18.20. SLM Solutions Group AG
  • 18.21. Stratasys Ltd.
  • 18.22. Voxeljet AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALUMINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALUMINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALUMINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CARBON FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CARBON FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CARBON FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY GLASS FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY GLASS FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY GLASS FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PHOTOPOLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PHOTOPOLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PHOTOPOLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BINDER JETTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BINDER JETTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BINDER JETTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DLP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DLP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DLP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CLOSED SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CLOSED SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CLOSED SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY OPEN SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY OPEN SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY OPEN SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYJET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYJET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYJET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LASER SLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LASER SLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LASER SLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DESKTOP PRINTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DESKTOP PRINTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DESKTOP PRINTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY INDUSTRIAL PRINTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY INDUSTRIAL PRINTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY INDUSTRIAL PRINTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALIGNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALIGNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ALIGNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY BRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CROWNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CROWNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CROWNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FACIAL PROSTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FACIAL PROSTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FACIAL PROSTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY FDM, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SLA, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PRINTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY PROSTHETICS, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY SURGICAL GUIDES, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 299. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 300. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 301. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 302. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 303. GCC 3D PRINTING CASTS IN HEALTHCARE MARKET SI